Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Potential Mechanism and Involvement of p120-Catenin in the Malignant Biology of Glioma

  • Leilei Wang (Department of Neurosurgery, Tianjin Medical University General Hospital) ;
  • Jianshen Liang (Department of Neurosurgery, Tianjin Medical University General Hospital) ;
  • Suzhen Ji (Department of Emergency, Cangzhou Central Hospital) ;
  • Chunlou Wang (Department of Pathology, Cangzhou Central Hospital) ;
  • Qiang Huang (Department of Neurosurgery, Tianjin Medical University General Hospital)
  • Received : 2024.02.29
  • Accepted : 2024.07.02
  • Published : 2024.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : This study analyzed the influence of p120-catenin (catenin [cadherin-associated protein], delta 1 [CTNND1]) on the malignant characteristics of glioma and elucidated the potential underlying mechanism. Methods : The p120 expression level was assessed in the brain tissues of 42 glioma patients and 10 patients with epilepsy by using the immunohistochemical method. Meanwhile, quantitative polymerase chain reaction (QT-PCR) technology was employed to assess the expression of p120 in the brain tissues of 71 glioma patients and 13 epilepsy patients. LN229, U251, and U87 glioma cells were used for in vitro analysis and categorized into four treatment groups : siRNA-blank control (BC) group (no RNA sequence was transfected), siRNA-negative control (NC) group (transfected control RNA sequences with no effect), and siRNA-1 and siRNA-2 groups (two p120-specific interfering RNA transfection). p120 expression in these treatment groups was quantified by western blotting assay. The migratory and invasive capabilities of glioma cells were studied by wound healing assay and Transwell invasion assay, respectively, under different treatment conditions. MTT (3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide) assay and cell cycle and apoptosis assay were used to determine glioma cell proliferation and apoptosis, respectively. Enzyme-labeled assay was performed to measure intracellular calcium ion concentration. Immunofluorescence assay was performed for determining microtubule formation and glioma cell distribution. Results : Brain tissues of the glioma group exhibited a remarkable increase in the p120 expression level as compared to brain tissues of the nontumor group (p<0.05). Furthermore, a strong positive correlation was noted between the malignancy degree in glioma brain tissues and p120 expression in Western blotting (r=0.906, p<0.0001) and QT-PCR (F=830.6, p<0.01). Compared to the BC and NC groups, the siRNA transfection groups showed a significant suppression in p120 expression in glioma cells (p<0.05), with a marked attenuation in the invasive, migratory, and proliferative capabilities of glioma cells as well as an increase in apoptotic potential (p<0.05). Enzyme-labeled assay showed a remarkable increase in calcium concentration in glioma cells after siRNA treatment. Immunofluorescence assay revealed that the microtubule formation ability of glioma cells reduced after siRNA treatment. Conclusion : p120 has a pivotal involvement in facilitating glioma cell invasion and proliferation by potentially modulating these processes through its involvement in microtubule formation and regulation of intracellular calcium ion levels.

Keywords

References

  1. Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Sure U, Thakur BK, et al. : Glioma: molecular signature and crossroads with tumor microenvironment. Cancer Metastasis Rev 41 : 53-75, 2022 
  2. Becchetti A : Chapter two - interplay of Ca2+ and K+ signals in cell physiology and cancer. Curr Top Membr 92 : 15-46, 2023 
  3. Boiarska Z, Passarella D : Microtubule-targeting agents and neurodegeneration. Drug Discov Today 26 : 604-615, 2021 
  4. Di Cristofori A, Basso G, de Laurentis C, Mauri I, Sirtori MA, Ferrarese C, et al. : Perspectives on (a)symmetry of arcuate fasciculus. A short review about anatomy, tractography and TMS for arcuate fasciculus reconstruction in planning surgery for gliomas in language areas. Front Neurol 12 : 639822, 2021 
  5. Dunach M, Del Valle-Perez B, Garcia de Herreros A : p120-catenin in canonical Wnt signaling. Crit Rev Biochem Mol Biol 52 : 327-339, 2017 
  6. Goodson HV, Jonasson EM : Microtubules and microtubule-associated proteins. Cold Spring Harb Perspect Biol 10 : a022608, 2018 
  7. Haag D, Zipper P, Westrich V, Karra D, Pfleger K, Toedt G, et al. : Nos2 inactivation promotes the development of medulloblastoma in Ptch1(+/-) mice by deregulation of Gap43-dependent granule cell precursor migration. PLoS Genet 8 : e1002572, 2012 
  8. Hatanaka K, Simons M, Murakami M : Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am J Physiol Heart Circ Physiol 300 : H162-H172, 2011 
  9. Hernandez A, Domenech M, Munoz-Marmol AM, Carrato C, Balana C : Glioblastoma: relationship between metabolism and immunosuppressive microenvironment. Cells 10 : 3529, 2021 
  10. Hong JY, Oh IH, McCrea PD : Phosphorylation and isoform use in p120-catenin during development and tumorigenesis. Biochim Biophys Acta 1863 : 102-114, 2016 
  11. Jiang G, Wang Y, Dai S, Liu Y, Stoecker M, Wang E, et al. : P120-catenin isoforms 1 and 3 regulate proliferation and cell cycle of lung cancer cells via β-catenin and Kaiso respectively. PLoS One 7 : e30303, 2012 
  12. Jiang Y, Liao L, Shrestha C, Ji S, Chen Y, Peng J, et al. : Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma. Int J Clin Exp Pathol 8 : 9042-9051, 2015 
  13. Jung E, Osswald M, Ratliff M, Dogan H, Xie R, Weil S, et al. : Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma. Nat Commun 12 : 1014, 2021 
  14. Krigers A, Demetz M, Moser P, Kerschbaumer J, Brawanski KR, Fritsch H, et al. : Impact of GAP-43, Cx43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas. Sci Rep 13 : 2024, 2023 
  15. Latario CJ, Schoenfeld LW, Howarth CL, Pickrell LE, Begum F, Fischer DA, et al. : Tumor microtubes connect pancreatic cancer cells in an Arp2/3 complex-dependent manner. Mol Biol Cell 31 : 1259-1272, 2020 
  16. Lee M, Ji H, Furuta Y, Park JI, McCrea PD : p120-catenin regulates REST and CoREST, and modulates mouse embryonic stem cell differentiation. J Cell Sci 127(Pt 18) : 4037-4051, 2014 
  17. Lou E : A ticket to ride: the implications of direct intercellular communication via tunneling nanotubes in peritoneal and other invasive malignancies. Front Oncol 10 : 559548, 2020 
  18. Maiden SL, Petrova YI, Gumbiner BM : Microtubules inhibit E-cadherin adhesive activity by maintaining phosphorylated p120-catenin in a colon carcinoma cell model. PLoS One 11 : e0148574, 2016 
  19. Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, et al. : Brain tumour cells interconnect to a functional and resistant network. Nature 528 : 93-98, 2015 
  20. Osswald M, Solecki G, Wick W, Winkler F : A malignant cellular network in gliomas: potential clinical implications. Neuro Oncol 18 : 479-485, 2016 
  21. Parato J, Bartolini F : The microtubule cytoskeleton at the synapse. Neurosci Lett 753 : 135850, 2021 
  22. Poff A, Koutnik AP, Egan KM, Sahebjam S, D'Agostino D, Kumar NB : Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma. Semin Cancer Biol 56 : 135-148, 2019 
  23. Portela M, Mitchell T, Casas-Tinto S : Cell-to-cell communication mediates glioblastoma progression in Drosophila. Biol Open 9 : bio053405, 2020 
  24. Przybylowski CJ, Hervey-Jumper SL, Sanai N : Surgical strategy for insular glioma. J Neurooncol 51 : 491-497, 2021 
  25. Roehlecke C, Schmidt MHH : Tunneling nanotubes and tumor microtubes in cancer. Cancers (Basel) 12 : 857, 2020 
  26. Saberbaghi T, Wong R, Rutka JT, Wang GL, Feng ZP, Sun HS : Role of Cl-channels in primary brain tumour. Cell Calcium 81 : 1-11, 2019 
  27. Venhuizen JH, Jacobs FJC, Span PN, Zegers MM : P120 and E-cadherin: double-edged swords in tumor metastasis. Semin Cancer Biol 60 : 107-120, 2020 
  28. Venkataramani V, Schneider M, Giordano FA, Kuner T, Wick W, Herrlinger U, et al. : Disconnecting multicellular networks in brain tumours. Nat Rev Cancer 22 : 481-491, 2022 
  29. Venkataramani V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wissmann N, et al. : Glioblastoma hijacks neuronal mechanisms for brain invasion. Cell 185 : 2899-2917.e31, 2022 
  30. Venkatesh VS, Lou E : Tunneling nanotubes: a bridge for heterogeneity in glioblastoma and a new therapeutic target? Cancer Rep (Hoboken) 2 : e1185, 2019 
  31. Wang X, Liang J, Sun H : The network of tumor microtubes: an improperly reactivated neural cell network with stemness feature for resistance and recurrence in gliomas. Front Oncol 12 : 921975, 2022 
  32. Watson DC, Bayik D, Storevik S, Moreino SS, Sprowls SA, Han J, et al. : GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat Cancer 4 : 648-664, 2023 
  33. Weil S, Osswald M, Solecki G, Grosch J, Jung E, Lemke D, et al. : Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas. Neuro Oncol 19 : 1316-1326, 2017 
  34. Wu H, Yan X, Zhao L, Li X, Li X, Zhang Y, et al. : p120-catenin promotes innate antiviral immunity through stabilizing TBK1-IRF3 complex. Mol Immunol 157 : 8-17, 2023 
  35. Xie R, Kessler T, Grosch J, Hai L, Venkataramani V, Huang L, et al. : Tumor cell network integration in glioma represents a stemness feature. Neuro Oncol 23 : 757-769, 2021 
  36. Xie Z, Tang Y, Man MQ, Shrestha C, Bikle DD : p120-catenin is required for regulating epidermal proliferation, differentiation, and barrier function. J Cell Physiol 234 : 427-432, 2018 
  37. Xu S, Tang L, Li X, Fan F, Liu Z : Immunotherapy for glioma: current management and future application. Cancer Lett 476 : 1-12, 2020 
  38. Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, et al. : Immunotherapy: a promising approach for glioma treatment. Front Immunol 14 : 1255611, 2023